Clinical Studies Show Bergamonte Exhibits Breakthrough Results for Healthy Blood Sugar and Cholesterol Support†

Mon Sep 27, 2010 2:20pm EDT

* Reuters is not responsible for the content in this press release.

"In just thirty days, you could see results of up toa 37% plunge in your LDL
cholesterol,a 49% decrease in your triglycerides, anda 22% drop in your blood
sugar levels.All that from a single, safe solution…instead of a handful of
potentially dangerous, but effectives drugs." - Michele Cagan, The Health
Sciences Institute
BRADENTON, Fla.--(Business Wire)--
HP LifeScience announces a natural product based on the Italian Fruit, Citrus
Bergamot - Bergamonte. A placebo controlled human clinical study involving 238
patients resulted in a 40% increase in HDL, a 36% decrease in LDL, a 39%
decrease in Triglycerides and a 22% decrease in Blood Glucose.† 

The health benefits shown are dramatically improved over phytosterols,
policosanol, red yeast rice and other natural products.† Bergamonte does all of
this without the harmful side effects of potentially harmful, but effective,
medications.† 

Citrus Bergamot comes from the lime family and is not to be confused with Citrus
Aurantium from China. Citrus Bergamot does not contain Synepherine.
N-methyltyramine, and Octopamine. These compounds found in Citrus Aurantium have
been shown in research to constrict arteries, increase blood pressure, increase
heart rate, cause heart-rhythm disorders, heart attack, and stroke. 

Citrus Bergamot contains novel compounds, Melitidine and Brutelidine that have
been shown in research to significantly reduce total cholesterol, LDL,
Triglycerides, Blood Glucose level, while increasing HDL. 

"4 flavonoids in Citrus Bergamot are linked to 3-metil-3-hydroxy glutarile
portion, which is exactly the substrate of HMG-CoA reductase, suggesting that
these compounds mimic endogenous HMG-CoA substrate and interfere with the
synthesis of mevalonate, a critical compound at the top of the cholesterol
synthesis pathway," explained Dr. Vincenzo Mollace MD, the lead research
scientist in the citrus bergamot human clinical research. 

"Clinical trial participants include patients with hypercholesterolemia,
patients with both hypercholesterolemia and hypertriglyceridemia. The trials
were double blind, placebo and we now have over 500 patients in clinical
studies," said Mollace. 

"Bergamonte will be available through HP LifeScience which specializes in
products for re-sale by Practitioners. Our products are based on Premier
Ingredients which target the issues of Metabolic Syndrome," said Carlos
Escalante. "These products include LJ100, Maqui Superberry, Paractin,Mucuna
Pruriens and Bergamonte for Practitioners to support their patients whole
health."

HP LifeScience
Carlos Escalante, 877-903-9657
carlos@hplifescience.com



Copyright Business Wire 2010